Nasal Splint segmentation by application reveals four dominant use‑cases that together account for the entire market. The largest share, approximately 45 % of revenue, originates from post‑operative ENT surgery, where splints are employed to maintain nasal airway patency after septoplasty, turbinectomy, or functional endoscopic sinus surgery. This segment drives volume growth through high procedure frequency and repeat usage across hospital networks. A second tier, representing about 30 % of the market, consists of facial trauma reconstruction; splints support bone alignment and soft‑tissue healing following mandibular or nasal fractures, contributing a steady demand from emergency and maxillofacial clinics. Cosmetic procedures, chiefly rhinoplasty, generate roughly 15 % of sales; the need for precise postoperative support creates a niche for premium, patient‑specific devices. The remaining 10 % is linked to pediatric airway stabilization, where splints are used in congenital or acquired obstruction cases, often in specialized children’s hospitals. Collectively, these application categories define the market’s revenue distribution and inform resource allocation for manufacturers.
